ACE2 and infection: Studies have shown that SARS-CoV-2 can infect not only ACE2-rich cells but also cells lacking ACE2, and the infection is resistant to monoclonal antibodies against spike RBD in vitro, suggesting that some human cells have ACE2-independent alternative receptors that mediate SARS-CoV-2 entry [14].